Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00567567 · OUTCOME

EFS Pts Non-randomly Assigned to Single CEM (12-18 Mths, Stg. 4, MYCN Nonamplified Tumor/Unfavorable or Indeterminant Histopathology/Diploid DNA Content & Pts>547 Days, Stg.3, MYCN Nonamplified Tumor AND Unfavorable or Indeterminant Histopathology).

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percent probability
Interval / dispersion
95% Confidence Interval
Time frame
Up to 3 years

What was measured

Kaplan-Meier curves of EFS will be plotted, and the proportion of responders to induction therapy will be tabulated.

Analysis population: All eligible patients non-randomly assigned to single CEM

Groups in this outcome

Single HST (CEM)

Induction therapy + single myeloablative consolidation

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Single HST (CEM)27

Reported measurements

Source class 1
Values in percent probability · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Single HST (CEM)73.1Not reported55.191.2Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        55.1
        upper Limit
        91.2
        value
        73.1
denoms
  1. counts
    1. group Id
      OG000
      value
      27
    units
    Participants
description
Kaplan-Meier curves of EFS will be plotted, and the proportion of responders to induction therapy will be tabulated.
dispersion Type
95% Confidence Interval
groups
  1. description
    Induction therapy + single myeloablative consolidation
    id
    OG000
    title
    Single HST (CEM)
param Type
NUMBER
population Description
All eligible patients non-randomly assigned to single CEM
reporting Status
POSTED
time Frame
Up to 3 years
title
EFS Pts Non-randomly Assigned to Single CEM (12-18 Mths, Stg. 4, MYCN Nonamplified Tumor/Unfavorable or Indeterminant Histopathology/Diploid DNA Content & Pts>547 Days, Stg.3, MYCN Nonamplified Tumor AND Unfavorable or Indeterminant Histopathology).
type
SECONDARY
unit Of Measure
percent probability

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice